In September 2015 first findings from the Prostate Cancer Registry were presented at the ESMO European Cancer Congress. Additional findings were presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in November 2015. At this occasion, the poster was nominated as a finalist for best poster from among 2300 submissions. Two sites in Luxembourg recruited a total of 15 registry participants.
The objective of this prospective, observational registry is to document the characteristics and management of patients with mCRPC in routine clinical practice, independent of treatment used.
The posters presented baseline characteristics, disease, treatment history and medical resource utilization based on the first analysis of a population of 505.
Please click on the links below to see the posters:
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.